Results 111 to 120 of about 36,016 (212)

Overlap Lamivudine Treatment in Patients with Chronic Hepatitis B Receiving Adefovir for Lamivudine-Resistant Viral Mutants

, 2009
Adefovir dipivoxil is effective against lamivudine-resistant hepatitis B virus (HBV) strains. Whether short-term overlap lamivudine is beneficial remains unknown, particularly in patients with decompensated chronic hepatitis B.
LIU, CHUN-JEN;KAO, JIA-HORNG;CHEN, PEI-JER;CHEN, T-C;LIN, FANG-YUE;LAI, MING-YANG;CHEN, DING-SHINN, 劉俊人;高嘉宏;陳培哲;陳聰智;林芳郁;賴明陽;陳定信   +1 more
core  

Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or Abacavir-Lamivudine

, 2011
Background Antiretroviral treatment (cART) in HIV causes lipoatrophy. We examined predictors of anthropometric outcomes over 96 weeks in HIV-infected, lipoatrophic adults receiving stable cART randomised to tenofovir-emtricitabine (TDF-FTC) or abacavir ...
Allison Humphries (20120436), Sean Emery (20135), David Baker (11642), Andrew Carr (157672), Mark Bloch (4925), Janaki Amin (157661), David A Cooper (16165874)   +6 more
core  

Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance

, 2015
Guiliang Wang,1,2 Yan Liu,2 Ping Qiu,1 Shu-Feng Zhou,3,4 Linfang Xu,1 Ping Wen,1 Jianbo Wen,1 Xianzhong Xiao5 1Department of Digestive Internal Medicine, Gannan Medical University Pingxiang Hospital, Pingxiang, People’s Republic of China ...
Xu L, Liu Y, Wen J, Zhou SF, Xiao X, Wen P, Wang G, Qiu P   +7 more
core  

Correlation between lamivudine plasma concentrations and patient self-reported adherence to antiretroviral treatment in experienced HIV patients

, 2011
OM Minzi1, V Mugoyela2, LL Gustafsson31Unit of Pharmacology and Therapeutics, 2Department of Medicinal Chemistry, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania; 3Division of Clinical Pharmacology ...
Mugoyela V, Gustafsson LL, Minzi OM
core  

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Lamivudine-induced muscle mitochondrial toxicity

, 2002
Lamivudine-induced muscle mitochondrial ...
Ojetti, Veronica, Santoliquido, Angelo, Gasbarrini, Antonio, Gentiloni Silveri, Nicolo', Agnes, Salvatore, Pola, Paolo, Migneco, Alessio, Flore, Roberto Antonio, De Martini, Demetrio   +8 more
core  

Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure

, 1998
We examined the in vitro phenotypic and genotypic profiles of an extensively passaged human immunodeficiency virus type 1 clinical isolate which has been selected for lamivudine resistance, with an M184V mutation in a zidovudine-resistant genetic ...
S. Kurtagic, P.M. Citterio, M. Galazzi, M. De Pasquale, S. Rusconi, M. Galli, L. Milazzo, E. Bulgheroni, S. La Seta-Catamancio   +8 more
core  

Tratamiento prolongado con interferón alfa-2b más lamivudina en pacientes con hepatitis crónica B y antígeno e positivo Prolonged treatment with alpha-2b interferon plus lamivudine in patients with e antigen positive chronic hepatitis B

Revista Cubana de Medicina, 2007
Las tasas de seroconversión del antígeno e alcanzadas con los antivirales actuales no sobrepasan el 35 %. La combinación de inmunomodulador y antiviviral ha sido teóricamente la estrategia más aceptada en los últimos años; sin embargo, los resultados en ...
Eduardo Vilar Gómez, Bienvenido Grá Orama, Enrique Arús Soler, Caridad Ruenes Domech, Yudith Dávila González   +4 more
doaj  

Treatment of patients with chronic hepatitis b in General hospital Celje

Zdravniški Vestnik, 2005
Background: A third of world’s population has serological evidence of a past or current infection with hepatitis B virus and 350 million people have chronic infection. Chronic hepatitis B is associated with liver cirrhosis and hepatic cancer, i.e.
Gorazd Lešničar
doaj  

Combined antiretroviral therapy with low- or normal-protein, high-calorie diets appears to induce significant deleterious electrocardiographic changes in a rodent model. [PDF]

Braz J Med Biol Res
Chege BM, Mwangi PW, Githinji CG, Bukachi F.   +3 more
europepmc   +1 more source